Fidia Complete is a best-in-class program for facilitating access and reimbursement for hyaluronic acid (HA) products

Complete support for your office to prescribe TRILURON^® with confidence

Quick turnaround (2 business days or less)

Patient-specific benefit investigations

Prior authorization applications and renewals

Appeals assistance

Specialty pharmacy triage

Real-time enrollment status updates

Allows for maximized visibility and the insight necessary to track a referral’s journey throughout the fulfillment process.

Support hotline 1-866-749-2542, Option 2

Reimbursement support
Physician support services

Available Monday-Friday, 9 AM to 8 PM ET

Fax: 1-877-447-9734

For patient insurance verification, register/login to: www.fidiacomplete.com

Resources for ordering and reimbursement

TRILURON^® Reimbursement Guide

Sample CMS 1450 Form

Benefit Investigation Patient Enrollment Form

Reimbursement Support Program Overview

Coding Information

Strategies to Appeal Denied Claims

Tips for Clean Claims Submission

Letter of Medical Necessity

Prior Authorization Checklist

Sample Letter of Appeal

Sample CMS 1500 Form

Fidia Complete Portal Registration Information

Indication

TRILURON^® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics, e.g., acetaminophen.

Important Safety Information

TRILURON^® is contraindicated in patients with known hypersensitivity to hyaluronate preparations or patients with infections/skin diseases in the area of the injection site/joint. The safety and effectiveness of TRILURON^® have not been established in pregnant women, nursing mothers, children, use in other joints, or concomitantly with other intra-articular (IA) injections. The effectiveness of a single treatment cycle of less than 3 injections has not been established.

Anaphylactoid and allergic reactions have been reported with this product. Transient increases in inflammation in the injected knee following TRILURON^® injection have been reported in some patients with inflammatory arthritis. Common adverse events include joint effusion/swelling/pain, injection site pain/hematoma, local skin reactions (rash, ecchymosis) and injection site warmth. Usually, local adverse events are transient and disappear spontaneously within a few days of resting the affected joint and/or applying ice locally. See package insert for full warnings, precautions and adverse events for more detail.

Rx Only.

Please see Full Prescribing Information.

Fidia Complete is a best-in-class program for facilitating access and reimbursement for hyaluronic acid (HA) products

Complete support for your office to prescribe TRILURON® with confidence

Real-time enrollment status updates

Support hotline 1-866-749-2542, Option 2

Resources for ordering and reimbursement

References

Complete support for your office to prescribe TRILURON^® with confidence